Covered recipient · General Payments record
CATHRIEN ABDELNOR
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$983.44
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $711.75 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Inari Medical, Inc. | $187.11 | 1 |
| Acerta Pharma LLC | $142.95 | 2 |
| Janssen Pharmaceuticals, Inc | $125.00 | 1 |
| Exact Sciences Corporation | $54.60 | 2 |
| PFIZER INC. | $54.25 | 3 |
| Lilly USA, LLC | $49.37 | 2 |
| Astellas Pharma US Inc | $44.87 | 2 |
| Merck Sharp & Dohme Corporation | $27.60 | 1 |
| Amgen Inc. | $26.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $26.00 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117183665 | CMS |
| Astellas Pharma US Inc | $15.78 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139396035 | CMS |
| Astellas Pharma US Inc | $29.09 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139428382 | CMS |
| AstraZeneca Pharmaceuticals LP | $123.50 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104746029 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.45 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105808326 | CMS |
| Exact Sciences Corporation | $28.21 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114568021 | CMS |
| Exact Sciences Corporation | $26.39 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114568025 | CMS |
| Inari Medical, Inc. | $187.11 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140054690 | CMS |
| Janssen Pharmaceuticals, Inc | $125.00 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077918097 | CMS |
| Lilly USA, LLC | $24.56 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136039767 | CMS |
| Lilly USA, LLC | $24.81 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136108986 | CMS |
| Merck Sharp & Dohme LLC | $27.60 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141830136 | CMS |
| PFIZER INC. | $22.67 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131531953 | CMS |
| PFIZER INC. | $17.30 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131538733 | CMS |
| PFIZER INC. | $14.28 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131546197 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.